Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism

The dosage of evocalcet required to control serum parathyroid hormone (PTH) levels varies among secondary hyperparathyroidism (SHPT) patients. This post hoc analysis evaluated the dose-dependent efficacy of evocalcet on serum intact PTH (iPTH) levels, corrected calcium (Ca) and phosphate (P) levels,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokumoto, Masanori, Tokunaga, Shin, Asada, Shinji, Endo, Yuichi, Kurita, Noriaki, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746983/
https://www.ncbi.nlm.nih.gov/pubmed/36512619
http://dx.doi.org/10.1371/journal.pone.0279078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746983/
https://www.ncbi.nlm.nih.gov/pubmed/36512619
http://dx.doi.org/10.1371/journal.pone.0279078

Ejemplares similares